Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.

Prabowo SA, Gröschel MI, Schmidt ED, Skrahina A, Mihaescu T, Hastürk S, Mitrofanov R, Pimkina E, Visontai I, de Jong B, Stanford JL, Cardona PJ, Kaufmann SH, van der Werf TS.

Med Microbiol Immunol. 2013 Apr;202(2):95-104. doi: 10.1007/s00430-012-0278-6. Epub 2012 Nov 10. Review.

PMID:
23143437
2.

[Recent progress in mycobacteriology].

Okada M, Kobayashi K.

Kekkaku. 2007 Oct;82(10):783-99. Japanese.

PMID:
18018602
3.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
4.

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.

Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho AC, Chang KC, Codecasa L, Correia A, Crudu V, Davies P, Dedicoat M, Drobniewski F, Duarte R, Ehlers C, Erkens C, Goletti D, Günther G, Ibraim E, Kampmann B, Kuksa L, de Lange W, van Leth F, van Lunzen J, Matteelli A, Menzies D, Monedero I, Richter E, Rüsch-Gerdes S, Sandgren A, Scardigli A, Skrahina A, Tortoli E, Volchenkov G, Wagner D, van der Werf MJ, Williams B, Yew WW, Zellweger JP, Cirillo DM; TBNET.

Eur Respir J. 2014 Jul;44(1):23-63. doi: 10.1183/09031936.00188313. Epub 2014 Mar 23.

5.

Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.

Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43.

7.

The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin.

Liang Y, Wu X, Zhang J, Li N, Yu Q, Yang Y, Bai X, Liu C, Shi Y, Liu Q, Zhang P, Li Z.

Vaccine. 2008 Aug 18;26(35):4536-40. doi: 10.1016/j.vaccine.2008.06.066. Epub 2008 Jul 9.

PMID:
18602439
8.

Drug-resistant tuberculosis: past, present, future.

Chiang CY, Centis R, Migliori GB.

Respirology. 2010 Apr;15(3):413-32. doi: 10.1111/j.1440-1843.2010.01738.x. Epub 2010 Mar 19. Review.

PMID:
20337989
9.

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update.

Falzon D, Jaramillo E, Schünemann HJ, Arentz M, Bauer M, Bayona J, Blanc L, Caminero JA, Daley CL, Duncombe C, Fitzpatrick C, Gebhard A, Getahun H, Henkens M, Holtz TH, Keravec J, Keshavjee S, Khan AJ, Kulier R, Leimane V, Lienhardt C, Lu C, Mariandyshev A, Migliori GB, Mirzayev F, Mitnick CD, Nunn P, Nwagboniwe G, Oxlade O, Palmero D, Pavlinac P, Quelapio MI, Raviglione MC, Rich ML, Royce S, Rüsch-Gerdes S, Salakaia A, Sarin R, Sculier D, Varaine F, Vitoria M, Walson JL, Wares F, Weyer K, White RA, Zignol M.

Eur Respir J. 2011 Sep;38(3):516-28. doi: 10.1183/09031936.00073611. Epub 2011 Aug 4.

10.

Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.

Migliori GB, Sotgiu G, Jaramillo E, Mirzayev F, Centis R, Colvin C, Richardson MD.

Int J Tuberc Lung Dis. 2009 Oct;13(10):1305-8.

PMID:
19793438
11.

Multidrug-resistant and extensively drug-resistant tuberculosis: a review.

Chan ED, Iseman MD.

Curr Opin Infect Dis. 2008 Dec;21(6):587-95. doi: 10.1097/QCO.0b013e328319bce6. Review.

PMID:
18978526
12.

Adjunct immunotherapies for tuberculosis.

Uhlin M, Andersson J, Zumla A, Maeurer M.

J Infect Dis. 2012 May 15;205 Suppl 2:S325-34. doi: 10.1093/infdis/jis197. Epub 2012 Mar 29. Review.

13.

Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.

Chang KC, Yew WW.

Respirology. 2013 Jan;18(1):8-21. doi: 10.1111/j.1440-1843.2012.02257.x. Review.

14.

Multidrug-resistant tuberculosis.

Zager EM, McNerney R.

BMC Infect Dis. 2008 Jan 25;8:10. doi: 10.1186/1471-2334-8-10.

15.

Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs.

Liang Y, Wu X, Zhang J, Yang Y, Wang L, Bai X, Yu Q, Li N, Li Z.

Scand J Immunol. 2011 Jul;74(1):42-6. doi: 10.1111/j.1365-3083.2011.02538.x.

16.

New treatment options for multidrug-resistant tuberculosis.

Field SK, Fisher D, Jarand JM, Cowie RL.

Ther Adv Respir Dis. 2012 Oct;6(5):255-68. Epub 2012 Jul 4. Review.

PMID:
22763676
17.

New drugs and vaccines for drug-resistant Mycobacterium tuberculosis infections.

Dover LG, Bhatt A, Bhowruth V, Willcox BE, Besra GS.

Expert Rev Vaccines. 2008 May;7(4):481-97. doi: 10.1586/14760584.7.4.481. Review.

PMID:
18444894
18.

[Multidrug-resistant tuberculosis].

Alcaide F, Santín M.

Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 13:54-60. Review. Spanish.

PMID:
19100168
19.

Multidrug- and extensively drug-resistant tuberculosis, Germany.

Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C; German TBNET Group.

Emerg Infect Dis. 2008 Nov;14(11):1700-6. doi: 10.3201/eid1411.080729.

20.
Items per page

Supplemental Content

Write to the Help Desk